Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Filings indexed 969 across all filing types
Latest filing 2014-10-03 Legal Proceedings Report
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
BOVIE 8-K RE: DERIVATIVE SETTLEMENT
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 2, 2014, reporting a court order and final judgment approving a settlement in a stockholder derivative action. It references a previous Form 8-K filing and includes legal event details. The content is about a legal proceeding update rather than financial results, management changes, or capital activities. The document length is short (2581 characters) and it is a current report on a specific event. This fits the category of Legal Proceedings Report (LTR) as it updates on significant lawsuits and regulatory actions involving the company.
2014-10-03 English
BOVIE 8-K RE: AUDIT
Audit Report / Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated September 30, 2014, reporting a change in the company's certifying accountant. It details the dismissal of the previous auditor and the appointment of a new auditor, including disclosures about audit opinions and disagreements. The content focuses on auditor changes and related disclosures rather than presenting financial statements or audit reports themselves. This matches the description of an Audit Report / Information filing, which includes standalone audit reports and related information such as changes in auditors. The document is not a full annual report or interim report, nor is it a simple announcement or certification letter. Therefore, the appropriate classification is AR (Audit Report / Information).
2014-10-03 English
FORM 4
Director's Dealing
2014-09-23 English
FORM 4
Director's Dealing
2014-09-23 English
FORM 4
Director's Dealing
2014-09-15 English
FORM 4
Director's Dealing
2014-09-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.